Lung cancer: alternative rearrangements--targeting ROS1 in NSCLC
- PMID: 25311353
- DOI: 10.1038/nrclinonc.2014.180
Lung cancer: alternative rearrangements--targeting ROS1 in NSCLC
Comment on
-
Crizotinib in ROS1-rearranged non-small-cell lung cancer.N Engl J Med. 2014 Nov 20;371(21):1963-71. doi: 10.1056/NEJMoa1406766. Epub 2014 Sep 27. N Engl J Med. 2014. PMID: 25264305 Free PMC article. Clinical Trial.
References
-
- N Engl J Med. 2014 Nov 20;371(21):1963-71 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical